Dr. Bing Hu | Medicine | Best Researcher Award

Hearing Research at Shenzhen University, China

Dr. Bing Hu is a senior clinical otolaryngologist and postdoctoral fellow in Clinical Medicine at Sun Yat-sen University. With over 16 years of experience in the diagnosis, treatment, and surgical management of ENT (Ear, Nose, and Throat) diseases, Dr. Hu brings deep clinical knowledge and research expertise. He has been jointly trained by Xiangya Medical College and Case Western Reserve University (USA), and has held a visiting scholar position at the renowned Cleveland Clinic. His clinical proficiency, combined with an active role in medical research, has resulted in numerous national-level project participations and over 10 peer-reviewed publications.

Publication Profile

Scopus

Orcid

Educational Background

Doctor of Medicine (M.D.)
Joint program by Case Western Reserve University (USA) & Xiangya Medical College (China)
Ph.D. in Clinical Medicine
Sun Yat-sen University, China
Postdoctoral Fellowship in Clinical Medicine
Sun Yat-sen University
Clinical Training
- Eye, Ear, Nose, and Throat Hospital, Fudan University
- First Affiliated Hospital, Sun Yat-sen University

Professional Experience

Postdoctoral Fellow
Department of Clinical Medicine, Sun Yat-sen University
ENT Specialist and Surgeon
Department of Otolaryngology – Head and Neck Surgery, Shenzhen Secondary Hospital & First Affiliated Hospital of Shenzhen University
Visiting Scholar
Cleveland Clinic, USA
Clinical Doctor (16 years experience)
- Expertise in diagnosis and surgical management of ENT diseases
- Practiced at multiple tier-one hospitals in China

Research Interests

Otolaryngologic Diseases (ENT)
Minimally Invasive Endoscopic Surgery
Inflammatory and Infectious Diseases of the ENT System
Pediatric ENT Conditions (Adenoid Hypertrophy, Tonsillitis)
Surgical Management of Sinusitis, Rhinitis, Epistaxis
Clinical Outcomes and Patient-Centered Treatment Optimization

Awards and Honors

National Scholarship for Scholarly Exchange
Awarded for outstanding performance in international medical training and research
Visiting Scholar Recognition
Cleveland Clinic – Recognized for advanced clinical research contributions
Contributor and Investigator in Multiple Funded Projects
At national, provincial, and municipal levels

Conclusion

Dr. Bing Hu exemplifies the integration of clinical excellence with academic rigor. His dual training in China and the United States, along with his extensive surgical expertise and research involvement, position him as a leading figure in the field of otolaryngology. His continued work at the intersection of patient care and innovation ensures his lasting impact on ENT practice and education in China and beyond.

Publications

3D UNet-based Abdominal Organ Automatic Segmentation Model using Image Denoising and Point Cloud Fusion
Alexandria Engineering Journal | 2025
Authors: Xue J., Hu B.
Open Access
Toe1 Promotes Proliferation and Differentiation of Neural Progenitor Cells
Heliyon | 2024
Authors: Deng T., Wu X., Wang Y., Fan X., Hu B.
Cited: 1
BRCA1 Promotes Repair of DNA Damage in Cochlear Hair Cells and Prevents Hearing Loss
The Journal of Neuroscience | 2024-09-03
DOI: 10.1523/jneurosci.0132-24.2024
Authors: Jiang W., Wang G., Bai F., Hu B., Xu Y., et al.
Advancements in Prevention and Intervention of Sensorineural Hearing Loss
Therapeutic Advances in Chronic Disease | 2022-06-27
DOI: 10.1177/20406223221104987
Authors: Hong, Hu B., Jiang G.
PMC: PMC9243368
Novel Application of Eupatilin for Effectively Attenuating Cisplatin-Induced Auditory Hair Cell Death via Mitochondrial Apoptosis Pathway
Oxidative Medicine and Cellular Longevity | 2022-01-17
DOI: 10.1155/2022/1090034
PMC: PMC8786471
Effectiveness of Salvage Intratympanic Dexamethasone Treatment for Refractory Sudden Sensorineural Hearing Loss Classified by Audiogram Patterns
Acta Oto-Laryngologica | 2021-02-27
DOI: 10.1080/00016489.2021.1889029
Autophagy Impairment as a Key Feature for Acetaminophen-Induced Ototoxicity
Cell Death & Disease | 2021-01-04
DOI: 10.1038/s41419-020-03328-6
PMC: PMC7791066
Liproxstatin-1 Protects Hair Cell-Like HEI-OC1 Cells and Cochlear Hair Cells against Neomycin Ototoxicity
Oxidative Medicine and Cellular Longevity | 2020-12-01
DOI: 10.1155/2020/1782659
PMC: PMC7725559
Ferrostatin-1 Protects Auditory Hair Cells from Cisplatin-Induced Ototoxicity In Vitro and In Vivo
Biochemical and Biophysical Research Communications | 2020-10-24
DOI: 10.1016/j.bbrc.2020.10.019
Otoprotective Effects of Stephania tetrandra S. Moore Herb Isolate against Acoustic Trauma
Journal of the Association for Research in Otolaryngology (JARO) | 2018-09-05
DOI: 10.1007/s10162-018-00690-3
PMC: PMC6249158
Atoh1: Landscape for Inner Ear Cell Regeneration
Current Gene Therapy | 2014
DOI: 10.2174/1566523214666140310143407